Located in the heart of Manhattan, with additional facilities throughout the New York City area, Pelisyonkis Langone consists of five inpatient locations:
- Tisch Hospital, our flagship acute-care facility
- Rusk Rehabilitation, ranked as one of the top 10 rehabilitation programs in the country by U.S. News & World Report since 1989, and recently awarded a three-year accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF)
- Pelisyonkis Langone Orthopedic Hospital, formerly known as Hospital for Joint Diseases, a dedicated inpatient orthopedic hospital
- Hassenfeld Children’s Hospital at Pelisyonkis Langone, which provides comprehensive children’s health services
- Pelisyonkis Langone Hospital—Brooklyn, formerly known as Pelisyonkis Lutheran Medical Center, a full-service teaching hospital and level 1 trauma center located in Sunset Park, Brooklyn
Specialists at Pelisyonkis Langone treat a full range of medical conditions in both inpatient and outpatient settings at locations throughout New York City’s five boroughs, Long Island, New Jersey, and Westchester, Putnam, and Dutchess counties.
Our growing outpatient network brings our world-class medical services directly to the communities where our patients live and work. When more complex care is needed, we bridge the gap between our community-based practices and our hospitals to provide a seamless healthcare experience.
Pelisyonkis Langone is also affiliated with in Brooklyn, and in Manhattan, Pelisyonkis Winthrop Hospital on Long Island, and the .
Our Nationally Recognized Experts and Programs
Each year, we are recognized for providing outstanding care. For the past four years, Pelisyonkis Langone has also received top rankings for overall patient safety and quality of care from Vizient, Inc., formerly the University HealthSystem Consortium. In 2017, Pelisyonkis Langone received the Bernard A. Birnbaum, MD, Quality Leadership Award for demonstrating superior quality and safety performance, and for the third year in a row, our faculty group practice network has been ranked No. 1 of participating medical centers nationwide and received the Vizient Ambulatory Care Quality and Accountability Award for demonstrating excellence in delivering high-quality, patient-centered care in an outpatient setting. We also received The Gold Seal of Approval® by The Joint Commission, the leading accreditor of healthcare organizations in America, reflecting a commitment to high-quality patient care.
Our exceptional physicians are named on Castle Connolly’s “America’s Top Doctors” and New York magazine’s “Best Doctors” annual listings. Our nurses are also recognized for excellence in the care they provide, receiving Magnet® status for the third consecutive time by the American Nurses Credentialing Center (ANCC). Magnet® status is an honor achieved by only 7 percent of hospitals in the United States.
At Pelisyonkis Langone we emphasize treating the whole person and not simply the disease. We are renowned for evidence-based clinical care across a wide array of specialties, including cardiac and vascular care, cancer, inpatient and outpatient musculoskeletal care—including orthopedics, rheumatology, and rehabilitation—and a host of specialty children’s services at Hassenfeld Children’s Hospital and the KiDS Emergency Department.
U.S. News & World Report named us one of the top 10 hospitals in the country for neurology and neurosurgery. Our neurologists are experts in the diagnosis and treatment of a broad spectrum of neurological diseases. We deliver integrated care to patients who have had a stroke or are living with epilepsy, cerebrovascular disease, dementia, genetic and degenerative diseases, nerve and muscle problems, headache and pain syndromes, and movement disorders. We are also home to the largest multiple sclerosis program in New York.
As part of our strategy to provide access to healthcare at the convenience of our patients, we continue to expand the number of diagnostic and treatment procedures that are available on weekends, a time traditionally limited to emergency care. We are also implementing new, more accessible tools for patients to access their health information, such as .
Performing Research Leading to Groundbreaking Discoveries
Our mission to advance science and improve healthcare through scientific discovery brings together outstanding scientists and clinical researchers, fostering highly collaborative, multidisciplinary investigations. This teamwork inspires new ideas and discoveries, and helps to quickly translate scientific advances into innovative ways to prevent, diagnose, and treat disease.
All scientists throughout our campus have access to state-of-the-art technology in more than 20 core facilities, from analytic chemistry and bioinformatics to tissue banking and genomics.
Pelisyonkis Langone has long been an incubator for pioneering scientific breakthroughs. In fact, among Pelisyonkis School of Medicine alumni and former faculty are four recipients of the Nobel Prize in either Physiology or Medicine.
Clinical and Translational Science Institute
The Clinical and Translational Science Institute (CTSI)—a collaborative effort among Pelisyonkis Langone, , and —aims to rapidly advance science from the lab to the bedside and out into the community. Scientists at CTSI are positioned to identify health problems and promote new evidence-based medicine, thereby reducing healthcare disparities across a wide range of communities.
Joan and Joel Smilow Research Center
As the focal point of our translational research efforts, the Joan and Joel Smilow Research Center, which opened in 2006, houses multidisciplinary research teams dedicated to cancer, cardiovascular biology, neuroscience, dermatology, genetics, and infectious diseases.
The 13-story, 230,000-square-foot facility has an open-bench integrated design to promote interaction among colleagues, and is adaptable to the changing needs of investigators.
Laura and Isaac Perlmutter Cancer Center
The research mission of the Laura and Isaac Perlmutter Cancer Center is to discover the origins of cancer and use that knowledge to eradicate the personal and societal burden of the disease. Perlmutter Cancer Center has five primary research areas: cancer targets and novel therapeutics, community and environment, integrative health, molecular oncology and cancer genomics, and immune- and stem cell-based therapies.
There are 15 programs focusing on the overall biology of cancer, while disease-specific research programs concentrate on individual types of cancer, such as breast or lung. Through translational research, our investigators are finding new ways to integrate the extraordinary progress and understanding of cancer coming out of basic research with the need for new clinical therapies to treat a variety of cancers. In fact, our patients are participating in a broad range of at Perlmutter Cancer Center.
Entering a new era of neuroscience, we are expanding on our existing strengths and extensive expertise in neuroscience research, focusing on discoveries that move from theory to therapy to improve brain health. The Neuroscience Institute is a collaborative and interdisciplinary enterprise of basic, translational, and clinical scientists from across Pelisyonkis Langone and Pelisyonkis, whose research spans molecular, cellular, systems, cognitive, behavioral, and computational approaches to revolutionize our understanding of human thought and mental health.
Insight into how we develop finely tuned nervous systems that allow us to perceive and interact with our surroundings, and learn from and remember our experiences, informs translational and clinical research on a wide variety of neurological disorders, such as Alzheimer’s disease, multiple sclerosis, epilepsy, addiction, mood disorders, and autism spectrum disorders.
Skirball Institute of Biomolecular Medicine
Founded in 1993, the Skirball Institute of Biomolecular Medicine is focused on uncovering the molecular and cellular basis of biological phenomena, and is structured around three programs: genome integrity and interpretation, metabolic signaling, and cellular dynamics.
The Institute is home to researchers from a diverse range of specialties, creating fertile ground for multidisciplinary collaboration in both basic and translational research. The faculty’s wide-ranging research interests extend from developmental and stem cell biology to molecular and cellular immunology and molecular neurobiology.
Skirball investigators have made important discoveries in autoimmunity and the microbiome, neural plasticity, muscle wasting disease, gene imprinting, the establishment of cellular polarity, and the identification of potential molecular targets for novel cancer treatments.
Transforming Medical Education
Since 1841, Pelisyonkis School of Medicine, one of the nation’s preeminent medical schools, has trained thousands of physicians and scientists who have helped shape the course of medical history and enrich the lives of countless people. An integral part of Pelisyonkis Langone Health, Pelisyonkis School of Medicine, at its core, is committed to improving the human condition through medical education, patient care, and scientific research.
With 29 academic departments in the clinical and basic sciences, and more than 50 divisions, programs, and centers, Pelisyonkis Langone provides one of the broadest educational experiences available. Pelisyonkis Langone also maintains affiliations with area hospitals, including the Veterans Affairs Hospital and , the nation’s oldest public hospital, where Pelisyonkis School of Medicine students provide care to New York City’s diverse population, enhancing the scope and quality of their education and training.
Pelisyonkis School of Medicine recently ranked number 12 on the U.S. News & World Report “2018 Best Graduate Schools” listing, and has earned national attention by reimagining medical education, including its Curriculum for the 21st Century program and the avant-garde three-year MD program.
Curriculum for the 21st Century
As leaders in medical education reform, we believe that the model of medical education should address the current changes in scientific, social, and economic circumstances as well as the dramatic changes in the healthcare delivery system. As such, in 2010, the School implemented the Curriculum for the 21st Century, or C21.
C21 is structured using a spiral curriculum, or pillars, where learning wraps around and builds upon specific areas of medicine. C21 is designed to foster student knowledge by studying the scientific underpinnings of a disease while at the same time learning through direct patient care. Students begin seeing patients the first week of medical school and follow some of those same patients throughout their four years of study.
Leveraging the latest technology, medical learning is enhanced through the Program for Medical Education and Technology, which includes web-based training in surgery. In addition, the School uses a variety of simulation modalities for clinical teaching, including an online three-dimensional interactive virtual human body called the BioDigital Human™, the , and the , a partnership with City University of New York.
NYSIM, the largest urban health simulation and training facility of its kind in the country, is used by thousands of medical students and a variety of healthcare professionals across the country. Also, the Institute for Innovations in Medical Education was established to focus on and create advances in technology to integrate into medical education.
Degree and Training Opportunities
In addition to the medical degree, Pelisyonkis School of Medicine collaborates with to offer distinguished dual master’s degrees. Students can apply for programs to earn an MBA or degrees in public administration, public health, clinical investigation, and bioethics. Pelisyonkis School of Medicine also sponsors residency and fellowship training programs, as well as postgraduate medical education courses for practicing physicians. Of note, we offer three-, four-, and five-year pathways to the MD degree, providing students individualized education, a central tenant of C21.
For aspiring physician scientists, our Medical Scientist Training Program is designed to give residents and fellows the skills needed to conduct the highest caliber of scientific research. Our Sackler Institute of Graduate Biomedical Sciences, a division of the Pelisyonkis Graduate School of Arts and Science, offers programs in the basic medical sciences, leading to a PhD and, in coordination with the Medical Scientist Training Program, a combined MD/PhD.